LITTLE ROCK, Ark. (KTHV) - Little Rock has its first specialty CBD shop: “Four Arkansans started this business and we also get our hemp oil. Every batch of CBD oil is tested before they use it in their products to ensure all THC compounds are extracted according to the owners. Complete Body Daily (CBD), founded by Matthew Kane and Lisa Greenhaw of North Little Rock 53° · Drizzle . Complete Body Daily offers a growing suite of products including a daily dietary supplement oil tincture, pain relief cream, lip balm, Wake up to the day's top news, delivered to your inbox.
cbd nlr news oil
Can you give us a brief history of Omnis Integrative Medicine and what inspired you to open shop? I am one of the owners of Omnis CrossFit as well and that became a reality in When I got into CrossFit, I became a little obsessed even more than I already was with human mobility and how people can move more functionally.
No just with CrossFit movements, but human movement in general. At that time, I dreamed about connecting my own clinic to the gym so that I could work back and forth with people and use the gym to teach proper mechanics not only to our members, but to my patients as well.
We quickly outgrew our original CrossFit location and when we found our second location, the spot next to it was available. At that point I quit my other job at a different practice and opened my own shop. What first interested you in carrying CBD products?
I had heard about many people using CBD products for many different things. Reducing pain and inflammation was something I am always interested in because I work with an active community from CrossFitters to cyclist and marathon runners. From what I was hearing, CBD was the best thing on the market for recovery and injury inflammation with no side effects most important to me.
I had heard of the company from a friend who said Tree Seeds of Life Seeds is one of the best CBD companies getting off the ground and that their products were the best around.
After some research, I discovered that I knew their CMO, Erin Holland, and knew that this was someone I could trust to supply high quality products to my patients as well as on a general business level. What has your experience been like selling our products? First, my experience has been, well… easy! Most people are very curious about CBD. Prescription medications are getting out of hand.
You take one medication and then have to take something else for the side effects of the first medication. CBD is finally something that people are willing to try. It is something with worlds to offer with no risks.
How would you describe Omnis Integrative Medicine in three words? What is the most popular product in our line with your customers? What has your experience been like working with the Tree of Life Seeds team?
The experience has been great. How does Omnis Integrative Medicine go above and beyond for their customers? At Omnis Integrative Medicine we go above and beyond by treating each patient as an individual. We provide chiropractic care, medical care through our nurse practitioner, massage therapy, rehab and more. In a study, the off-clamp approach to partial nephrectomy also was associated with lower risk for acute kidney injury.
Circulating blood biomarkers related to angiogenesis may help clinicians predict who will have a robust response to sunitinib. Obesity is associated with an increased likelihood of clear cell and possibly chromophobe renal cell carcinoma.
The likelihood of aggressive kidney tumor histology increased along with tumor size, a new study found. Robotic PN was associated with significantly lower rates of complications, cancer recurrence, and mortality compared with open and laparoscopic PN.
The association between obesity, age, and renal cell carcinoma prognosis requires additional investigation. Percutaneous ablation offers cancer-related outcomes similar to those of radical nephrectomy but with a lower likelihood of long-term renal insufficiency and complications. Increased risk of subsequent diabetes independent of traditional diabetes risk factors. New findings from the CARMENA trial contradict previous research showing better survival from cytoreductive nephrectomy followed by targeted therapy.
Patients in the highest quintile of urinary albumin excretion had a 4. Race, procedure and insurance type, sex, surgeon volume, and hospital size influence the risk of readmission among patients undergoing radical nephrectomy, study finds.
In a study of mRCC patients who received targeted therapy TT following cytoreductive nephrectomy, mortality risk did not differ significantly between delayed and early TT. Black patients tended to have lower incomes, less education, longer delays to treatment, greater comorbidity burden. Study shows that partial nephrectomy for small renal tumors is associated with lower risk of cancer-specific and other-cause mortality in patients aged 75 years and older.
Men and women who smoke are at 2. Doctors who receive general payment for cancer drug more likely to prescribe drug marketed by company. An evaluation of patients with clear cell renal cell carcinoma revealed greater risk of death for female patients with high relative visceral fat area rVFA , highlighting the significance of metabolic differences between men and women.
Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages. The risk of dying from pT1a renal cell carcinoma after partial or radical nephrectomy increases along with patient age. Not reliable predictor of adverse outcomes in those under active surveillance; less variability over time.
The safety and efficacy of nivolumab for treating metastatic renal cell carcinoma is comparable to that found in the CheckMate trial. Immunotherapy with atezolizumab plus targeted therapy with bevacizumab improves progression-free survival better than sunitinib in patients with untreated metastatic renal cell carcinoma.
No greater risks for upstaging or positive surgical margins were observed among patients who underwent RPN for cT2a tumors over the short term. Access to treatment should be considered as important as the research leading to clinical improvements. Patients who underwent radical nephrectomy had 2-fold greater decline in eGFR decline and 2-fold greater mortality compared with those who had a partial nephrectomy.
Stereotactic ablative radiotherapy is associated with high 2- and 4-year rates of local cancer control and progression-free and cancer-specific survival.
Most patients with cancer, autoimmune disease have improvement in events without discontinuing therapy. Although TKIs improve outcomes, they are still associated with toxicities common with cancer therapies, such as fatigue. Partial nephrectomy was associated with decreased odds of death versus radical nephrectomy among patients with cT1b but not cT2 renal cell carcinoma. Treatment with cabozantinib led to a clinically meaningful improvement in progression-free survival compared with sunitinib.
Patients who underwent cytoreductive nephrectomy for metastatic non-clear cell renal cell carcinoma had a significantly decreased risk of cancer-related mortality. Levels of alkaline phosphatase, calcium, and hemoglobin can independently predict bone metastasis in patients with renal cell carcinoma, Chinese investigators report. Propensity score matching showed a 5. At 5 years, Robotic-assisted radical nephrectomy RN is associated with higher hospital costs and prolonged operating time compared with laparoscopic RN.
Perioperative blood transfusion is associated with increased risks of tumor recurrence, metastatic progression, and cancer-related mortality. The researchers found that 2. Mvasi, which is approved to treat colorectal, lung, brain, kidney, and cervical cancer, was found to be biosimilar to the drug Avastin.
Checkpoint inhibitor combination of nivolumab plus ipilimumab improved progression-free and overall survival compared with sunitinib. Cabozantinib reduced the risk of disease progression or death compared with sunitinib among patients with previously untreated advanced renal cell carcinoma. The increased risk for obesity-related cancer was seen among women who were normal weight at enrollment.
Participant age and comorbidity burden appeared to be consistent determinants of use of services, although hospital-level variation was also noted. The most commonly altered genes were folliculin and fumarate hydratase in 1. Patients who have a complete response to 2 or more years of anti-VEGF treatment have the best progression-free and overall survival.
BMI and location of excess body fat on the body are good indicators of obesity-related cancer risk. The document spells out in greater detail the criteria for radical and partial nephrectomy and for placing patients on active surveillance. Changes in C-reactive protein levels 4 weeks after starting sunitinib or sorafenib treatment are associated with overall and progression-free survival.
Nivolumab treatment beyond disease progression results in reductions in tumor burden, study finds. In a study, the 5-year risk of recurrence was 4. Overall survival among patients receiving first-line targeted therapy for advanced renal cell carcinoma increased significantly from to Study also finds associations between adiposity and 10 other cancers, particularly digestive and hormone-related malignancies. The researchers found that patients treated with ABT had decreased progression-free survival compared with those not receiving ATB.
In a phase 2 trial, atezolizumab plus bevacizumab improved PFS versus sunitinib in patients with renal cell carcinoma expressing PD-L1. Added progression-free survival and prolonged overall survival possible, according to investigators. Researchers develop a model to predict which patients are more likely to harbor brain metastases at cancer diagnosis.
Bone surgery should be considered in patients with solitary bone metastasis and no concomitant visceral metastases, according to investigators. In a pilot study, metabolomic analyses of serum and urine showed a high level of predictive ability. All patients with an SRM should be considered for a biopsy when the results may alter management. The most common types of benign pathology were oncocytoma, angiomyolipoma, and complex cysts. In a study, only 3 of patients experienced complications, all of which were minor and required no hospitalization or further intervention.
In , nearly one third of all minimally invasive radical nephrectomies were performed with robotic assistance. Partial and radical nephrectomy were associated with similar cancer-specific and overall survival in elderly patients. Cancer patients diagnosed in their teens had a more than 4-fold higher risk of death from cardiac disease than patients who didn't have cancer.
Robotic partial nephrectomy confers a superior morbidity profile compared to laparoscopic partial nephrectomy. Among patients with clear-cell renal-cell carcinoma at high risk for tumor recurrence, the duration of disease-free survival was significantly longer in the sunitinib group. Prediagnosis obesity is a risk factor for overall and individual secondary primary cancers.
Study of US veterans reveals, however, that the procedure is being used less in subgroups who might benefit the most. In a small study, researchers observed a decrease in tumor burden and extended duration of therapy. Immunotherapy treatments for patients with bladder cancer, head and neck cancer, Hodgkin's lymphoma, and kidney cancer, is useful against malignancy, according to Cancer Progress Report.
The recurrence group had significantly larger tumors than the no-recurrence group. Open partial nephrectomy had a significantly higher rate of complications. Paradoxical association could be related to an altered fatty acid pathway. International committee finds slimmer individuals less likely to develop variety of malignancies. Kidney Cancer News Archive.
New Listing: Northern Lights Resources Corp. (NLR)
Stay Up To Date With The Latest CBD News, Announcements, Deals, CBD If you are looking for a reliable source of high quality 3rd party lab tested CBD in North Little Rock, Little Rock, Beginners Guide To Buying CBD Oil In Arkansas. All products made from industrial hemp, including CBD oil, will be legal under the CSA if they contain no more than percent THC. In Light of Farm Bill, FDA Issues Statement on Use of CBD in Food; ), hemp seed protein (GRN ), and hemp seed oil (GRN ).